This statistic shows the leading pharmaceutical and biotechnology companies originated from the United Kingdom (UK), as of late 2023, based on market capitalization. As of October of that year, GlaxoSmithKline (GSK) ranked second highest on the list with a market capitalization of some 62 billion British pounds. First was British-Swedish firm AstraZeneca with a market capitalization of around 168 billion British pounds.
GlaxoSmithKline
GlaxoSmithKline is a British pharmaceutical company with its headquarters based in London, United Kingdom. The company manufactures products for major disease areas including respiratory disorders such as asthma, oncology, immuno-inflammatory disorders, cardiovascular diseases, as well as manufacturing vaccinations. One of the most successful drugs manufactured and patented by GSK was Seretide/Advair which is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). However, until 2020, sales of the drug Seretide/Advair dropped to 287 million British pounds in Europe.
Leading pharmaceutical and biotechnology companies in the United Kingdom (UK) as of 2023, based on market capitalization
(in billion GBP)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Financial Times. (October 19, 2023). Leading pharmaceutical and biotechnology companies in the United Kingdom (UK) as of 2023, based on market capitalization (in billion GBP) [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/443037/market-value-leading-pharmaceutical-biotechnology-companies-united-kingdom-uk/
Financial Times. "Leading pharmaceutical and biotechnology companies in the United Kingdom (UK) as of 2023, based on market capitalization (in billion GBP)." Chart. October 19, 2023. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/443037/market-value-leading-pharmaceutical-biotechnology-companies-united-kingdom-uk/
Financial Times. (2023). Leading pharmaceutical and biotechnology companies in the United Kingdom (UK) as of 2023, based on market capitalization (in billion GBP). Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/443037/market-value-leading-pharmaceutical-biotechnology-companies-united-kingdom-uk/
Financial Times. "Leading Pharmaceutical and Biotechnology Companies in The United Kingdom (Uk) as of 2023, Based on Market Capitalization (in Billion Gbp)." Statista, Statista Inc., 19 Oct 2023, https://www-statista-com.ezproxy.canberra.edu.au/statistics/443037/market-value-leading-pharmaceutical-biotechnology-companies-united-kingdom-uk/
Financial Times, Leading pharmaceutical and biotechnology companies in the United Kingdom (UK) as of 2023, based on market capitalization (in billion GBP) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/443037/market-value-leading-pharmaceutical-biotechnology-companies-united-kingdom-uk/ (last visited November 10, 2024)
Leading pharmaceutical and biotechnology companies in the United Kingdom (UK) as of 2023, based on market capitalization (in billion GBP) [Graph], Financial Times, October 19, 2023. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/443037/market-value-leading-pharmaceutical-biotechnology-companies-united-kingdom-uk/
